Humanized model to study leukemic stem cells

Methods in Molecular Biology

Volumn 538, Issue , 2009, Pages 247-262

  Bonnet, Dominique ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Hematopoietic stem cell (HSC); Immunodeficient mice; Leukemic stem cell (LSC); Xenotransplantation

Indexed keywords

MUS;

IL2RG PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR GAMMA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOPTIVE TRANSFER; ANIMAL; ARTICLE; CANCER STEM CELL; DISEASE MODEL; EXPERIMENTAL LEUKEMIA; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS;

EID: 65649089493     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-418-6_12     Document Type: Article

References (27)

1. Grimwade, D., Walker, H., Harrison, G., Oliver, F., Chatters, S., Harrison, C. J., et al. (2001). The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98, 1312-1320.
2. Grimwade, D., Walker, H., Oliver, F., Wheat- ley, K., Harrison, C., Harrison, G., et al. (1998). The importance of diagnostic cytoge-netics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92, 2322-2333. (Pubitemid 28452973)
3. Pearce, D. J., Taussig, D., Zibara, K., Smith, L. L., Ridler, C. M., Preudhomme, C., et al. (2006). AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 107, 1166-1173. (Pubitemid 43156319)
4. Christianson, S. W., Greiner, D. L., Hesselton, R. A., Leif, J. H., Wagar, E. J., Schweitzer, I. B., et al. (1997). Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 158, 3578-3586. (Pubitemid 127488709)
5. Glimm, H., Eisterer, W., Lee, K., Cashman, J., Holyoake, T. L., Nicolini, F., et al. (2001). Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 107, 199-206. (Pubitemid 32096836)
6. Kollet, O., Peled, A., Byk, T., Ben-Hur, H., Greiner, D., Shultz, L., et al. (2000). beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95, 3102-3105. (Pubitemid 30321160)
7. Hiramatsu, H., Nishikomori, R., Heike, T., Ito, M., Kobayashi, K., Katamura, K., et al. (2003). Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood 102, 873-880. (Pubitemid 36917778)
8. Yahata, T., Ando, K., Nakamura, Y., Ueyama, Y., Shimamura, K., Tamaoki, N., et al. (2002). Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169, 204-209. (Pubitemid 34686137)
9. Ishikawa, F., Yasukawa, M., Lyons, B., Yosh- ida, S., Miyamoto, T., Yoshimoto, G., et al. (2005). Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106, 1565-1573. (Pubitemid 41208567)
10. Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., et al. (2005). Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemo-poietic stem cells. J Immunol 174, 6477-6489. (Pubitemid 40663843)
11. Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A., et al. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104-107. (Pubitemid 38451466)
12. Mazurier, F., Doedens, M., Gan, O. I., and Dick, J. E. (2003). Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 9, 959-963. (Pubitemid 36889941)
13. Wang, J., Kimura, T., Asada, R., Harada, S., Yokota, S., Kawamoto, Y., et al. (2003). SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 101, 2924-2931. (Pubitemid 36857976)
14. Yahata, T., Ando, K., Sato, T., Miyatake, H., Nakamura, Y., Muguruma, Y., et al. (2003). A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101, 2905-2913. (Pubitemid 36857974)
15. Bonnet, D., and Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hemat-opoietic cell. Nat Med 3, 730-737. (Pubitemid 27298715)
16. Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M., and Sutherland, H. J. (1997). Lack of expression of Thy-1 (CD90) on acute mye-loid leukemia cells with long-term prolif-erative ability in vitro and in vivo. Blood 89, 3104-3112. (Pubitemid 27229792)
17. Blair, A., Hogge, D. E., and Sutherland, H. J. (1998). Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR. Blood 92, 4325-4335. (Pubitemid 28544350)
18. Blair, A., and Sutherland, H. J. (2000). Primi- tive acute myeloid leukemia cells with longterm proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol 28, 660-671. (Pubitemid 30398523)
19. Jordan, C. T., Upchurch, D., Szilvassy, S. J., Guzman, M. L., Howard, D. S., Pettigrew, A. L., et al. (2000). The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14, 1777-1784.
20. Taussig, D. C., Pearce, D. J., Simpson, C., Rohatiner, A. Z., Lister, T. A., Kelly, G., et al. (2005). Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106, 4086-4092. (Pubitemid 41775913)
21. Wang, J. S., Fang, Q., Sun, D. J., Chen, J., Zhou, X. L., Lin, G. W., et al. (2001). Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycy-clophosphamide, vincristine, and daunoru-bicin. Acta Pharmacol Sin 22, 949-955. (Pubitemid 32928989)
22. Duester, G. (2000). Families of retinoid dehy- drogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 267, 4315-4324. (Pubitemid 30461062)
23. Kastan, M. B., Schlaffer, E., Russo, J. E., Colvin, O. M., Civin, C. I., and Hilton, J. (1990). Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 75, 1947-1950.
24. Jones, R. J., Barber, J. P., Vala, M. S., Col- lector, M. I., Kaufmann, S. H., Ludeman, S. M., et al. (1995). Assessment of aldehyde dehydrogenase in viable cells. Blood 85, 2742-2746.
25. Pearce, D. J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A. Z., Lister, T. A., et al. (2005). Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 23, 752-760. (Pubitemid 40791790)
26. Hope, K. J., Jin, L., and Dick, J. E. (2004). Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5, 738-743. (Pubitemid 39023306)
27. Verlinden, S. F., van Es, H. H., and van Bek- kum, D. W. (1998). Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp Hematol 26, 627-630. (Pubitemid 28307531)